Evidence map›Paper›PMID 21831310›Full record

ArticleJournal of the International AIDS Society2011

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

M Eugenia Socías, Omar Sued, Natalia Laufer, María E Lázaro, Horacio Mingrone, Daniel Pryluka, Carlos Remondegui, María I Figueroa, Carina Cesar, Ana Gun and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

M Eugenia SocíasHospital J.A. Fernández, Cerviño 3356, Buenos Aires, Argentina. eugenia_socias@yahoo.com.ar
Omar Sued
Natalia Laufer
María E Lázaro
Horacio Mingrone
Daniel Pryluka
Carlos Remondegui
María I Figueroa
Carina Cesar
Ana Gun
Gabriela Turk
María B Bouzas
Ravi Kavasery
Alejandro Krolewiecki
Héctor Pérez
Horacio Salomón
Pedro Cahn
Grupo Argentino de Seroconversión Study Group
Fundación Huésped · ARHospital Fernández · ARHospital Muñiz · ARUniversity of Buenos Aires · ARYale University · US

Funding

Mount Sinai-New York State-Argentina HIV Prevention ProgramD43TW001037 · FIC · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI INDYK, DEBBIE S · 2000 to 2011
$4.1M
FIC NIH HHS D43 TW 001037
6 · The paper itself

Abstract

backgroundDiagnosis of primary HIV infection (PHI) has important clinical and public health implications. HAART initiation at this stage remains controversial.

methodsOur objective was to identify predictors of disease progression among Argentinean seroconverters during the first year of infection, within a multicentre registry of PHI-patients diagnosed between 1997 and 2008. Cox regression was used to analyze predictors of progression (LT-CD4 < 350 cells/mm3, B, C events or death) at 12 months among untreated patients.

resultsAmong 134 subjects, 74% presented with acute retroviral syndrome (ARS). Seven opportunistic infections (one death), nine B events, and 10 non-AIDS defining serious events were observed. Among the 92 untreated patients, 24 (26%) progressed at 12 months versus three (7%) in the treated group (p = 0.01). The 12-month progression rate among untreated patients with ARS was 34% (95% CI 22.5-46.3) versus 13% (95% CI 1.1-24.7) in asymptomatic patients (p = 0.04). In univariate analysis, ARS, baseline LT-CD4 < 350 cells/mm3, and baseline and six-month viral load (VL) > 100,000 copies/mL were associated with progression. In multivariate analysis, only ARS and baseline VL > 100,000 copies/mL remained independently associated; HR: 8.44 (95% CI 0.97-73.42) and 9.44 (95% CI 1.38-64.68), respectively.

conclusionsIn Argentina, PHI is associated with significant morbidity. HAART should be considered in PHI patients with ARS and high baseline VL to prevent disease progression.

Indexed as

Viral LoadAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveArgentinaDisease ProgressionFemaleHIVHIV InfectionsHumansMaleTime FactorsTreatment OutcomeAnti-HIV Agents

Identifiers

PMID21831310
PMCPMC3179691
OpenAlexW2121605220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.